Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions

NCT05894863 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-06-08

No results posted yet for this study

Summary

This study aims to evaluate the effectiveness and safety of the Smart flex stent system in treating long femoropopliteal native lesions.

Conditions

  • Peripheral Arterial Disease

Interventions

DEVICE

Smart flex stent

Smart flex stent will be used for femoropopliteal occlusive lesions.

Sponsors & Collaborators

  • Xuanwu Hospital, Beijing

    collaborator OTHER
  • Second Affiliated Hospital of Soochow University

    collaborator OTHER
  • First Affiliated Hospital of Zhejiang University

    collaborator OTHER
  • First People's Hospital of Hangzhou

    collaborator OTHER
  • Qingdao Haici Hospital

    collaborator OTHER
  • Liyuan Hospital of Tongji Medical College, Huazhong University of Science and Technology

    collaborator OTHER
  • Fudan University

    collaborator OTHER
  • Dongfang Hospital Beijing University of Chinese Medicine

    collaborator OTHER
  • Xiamen Cardiovascular Hospital, Xiamen University

    collaborator OTHER
  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Meng Ye, M.D. · Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiaotong University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-31
Primary Completion
2026-01-02
Completion
2027-01-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05894863 on ClinicalTrials.gov